Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283257 · ClinicalTrials.gov registry record · NA
Simultaneous Care: Linking Palliation to Clinical Trials
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 441
- Enrollment target
NCT00283257: Completed NA study, sponsored by University of California, Davis.
NCT00283257 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 441 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00283257, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 441 participants
- Enrollment target
Study Summary
This is a multi-site randomized control trial taking place at six cancer centers. UC Davis is the lead site. Additional performance sites include the City of Hope Medical Center, Fred Hutchinson Cancer Center at the Univ. of Washington, USC Norris Cancer Center, UCSD Cancer Center, and Johns Hopkins Cancer Center. Clinical trial patients and their caregivers who are randomized to the intervention arm of the study are scheduled for three educational sessions. The sessions focus on teaching problem solving skills based on the COPE problem solving model.
Interventions
- BEHAVIORAL Patients and caregivers are taught problem solving skills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 441 participants |
| Start Date | 2002-02 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT00283257 record still lists
NCT00283257 is an interventional study that assigns participants to a tested intervention. The registered 441 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which Patients and caregivers are taught problem solving skills is the first listed.
NCT00283257 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00283257 about?
NCT00283257 is a clinical study titled "Simultaneous Care: Linking Palliation to Clinical Trials". This is a multi-site randomized control trial taking place at six cancer centers. UC Davis is the lead site. Additional performance sites include the City of Hope Medical Center, Fred Hutchinson Cancer Center at the Univ. of Washington, USC Norris Cancer Center, UCSD Cancer Center, and Johns Hopkins...
What is the current status of trial NCT00283257?
This trial is currently completed. It is a NA study. The enrollment target is 441 participants. The study started on 2002-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00283257?
The interventions under investigation include: Patients and caregivers are taught problem solving skills (BEHAVIORAL).
Who is sponsoring clinical trial NCT00283257?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00283257's enrollment target sits among peer trials
441 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02679144 · 441 participants · Phase 2
Neuroblastoma Maintenance Therapy Trial
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia